Financial News

Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

79.41 -5.05 (-5.98%)

Delayed Quote Updated: 4:00 PM EST, Nov 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

51 52 Next >

S&P 500 Top Movers: Nov. 6, 2026 Gainers and Losers ↗

November 06, 2026

Via Chartmill

Topics Stocks

S&P 500 Top Movers: Gainers and Losers on Nov. 6, 2026 ↗

November 06, 2026

Via Chartmill

Topics Stocks

2 cash-producing stocks to research further and 1 facing challenges

November 05, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not...

Via StockStory

2 profitable stocks on our buy list and 1 we avoid

November 04, 2026

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...

Via StockStory

DexCom (NASDAQ:DXCM): Affordable Growth at a Reasonable Valuation ↗

October 13, 2026

Via Chartmill

DexCom (NASDAQ:DXCM): Strong Growth Paired With a High-Quality Technical Setup ↗

October 02, 2026

Via Chartmill

AdaptHealth, Align Technology, Acadia Healthcare, DexCom, and STERIS shares are soaring, what you need to know

November 04, 2026

What happened? A number of stocks jumped in the afternoon session after election results confirmed that Democrats reclaimed majorities in the House and Senat...

Via StockStory

Dexcom Invites the Global Diabetes Community to Share Their Stories Through A Letter to Diabetes Campaign

November 02, 2026

From DexCom, Inc.

Via Business Wire

3 quality compounders with promising prospects

November 01, 2026

A quality compounder is a business that not only sports durable competitive advantages but also builds on its success by consistently reinvesting its profits...

Via StockStory

S&P 500 Unusual Volume Movers for Oct. 30, 2026 ↗

October 30, 2026

Via Chartmill

Topics Stocks

DXCM Q3 deep dive: clinical momentum and new product launches support growth trajectory

October 30, 2026

Medical device company DexCom (NASDAQ:DXCM) reported revenue ahead of Wall Street’s expectations in Q3 2026, with sales up 11.2% year on year to $1.34 billio...

Via StockStory

Dexcom (DXCM) Q3 2026 Earnings Call Transcript ↗

October 30, 2026

Record patient starts and type 2 diabetes share gains fuel 11% revenue growth.

Via The Motley Fool

Topics Earnings

What DexCom (DXCM) Said on Its Q3 Earnings Call ↗

October 29, 2026

DexCom (NASDAQ:DXCM) reported third-quarter 2026 revenue of $1.34 billion, up 11% from a year earlier on both a reported and organic basis, as U.S. growth, market-share gains and manufacturing...

Via MarketBeat

Topics Earnings Initial Public Offering

2 Stocks That Could Quietly Become Big Winners in the Artificial Intelligence (AI) Revolution ↗

October 29, 2026

These aren’t top AI stocks, but the technology is helping improve their businesses.

Via The Motley Fool

Topics Artificial Intelligence

DexCom (NASDAQ:DXCM) beats Q3 2026 sales expectations

October 29, 2026

Medical device company DexCom (NASDAQ:DXCM) reported Q3 2026 results beating Wall Street’s revenue expectations, with revenue up 11.2% year on year to $1.34 ...

Via StockStory

Dexcom Reports Third Quarter 2026 Financial Results

October 29, 2026

From DexCom, Inc.

Via Business Wire

Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch in Canada in November

October 28, 2026

From DexCom, Inc.

Via Business Wire

What to expect from DexCom’s (DXCM) Q3 earnings

October 27, 2026

Medical device company DexCom (NASDAQ:DXCM) will be reporting results this Thursday after the bell. Here’s what investors should know. DexCom beat analysts’ ...

Via StockStory

S&P 500 Unusual Volume Movers in Today's Session ↗

October 22, 2026

Via Chartmill

Topics Stocks

S&P 500 Top Movers: Oct. 21, 2026 US Session ↗

October 21, 2026

Via Chartmill

Topics Stocks

S&P 500 Top Movers on Oct. 21, 2026: Supermicro Leads Gainers, Dexcom Leads Losers ↗

October 21, 2026

Via Chartmill

Topics Stocks

These S&P500 stocks that are showing activity before the opening bell on Thursday. ↗

October 15, 2026

Via Chartmill

Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin

October 14, 2026

From DexCom, Inc.

Via Business Wire

Dexcom Schedules Third Quarter 2026 Earnings Release and Conference Call for October 29, 2026 at 4:30 p.m. Eastern Time

October 07, 2026

From DexCom, Inc.

Via Business Wire

Uncover the latest developments among S&P500 stocks in today's session. ↗

October 06, 2026

Via Chartmill

Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading

October 06, 2026

From DexCom, Inc.

Via Business Wire

Which S&P500 stocks are moving on Tuesday? ↗

October 06, 2026

Via Chartmill

Tuesday's session: gap up and gap down stock in the S&P500 index ↗

October 06, 2026

Via Chartmill

Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care

September 28, 2026

From DexCom, Inc.

Via Business Wire

2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds

September 25, 2026

Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

51 52 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Financial News

DexCom, Inc. - Common Stock (NQ:DXCM)

All News about DexCom, Inc. - Common Stock

Popular Pages